Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

Breast cancer: an up‐to‐date review and future perspectives
Ruoxi Hong, Binghe Xu
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 913-936
Open Access | Times Cited: 191
Study of Iron Complex Photosensitizer with Hollow Double‐Shell Nano Structure Used to Enhance Ferroptosis and Photodynamic Therapy
Xinrui Cai, Weixing Liu, Jiahao Zhang, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 10
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides
Erik N. Bergstrom, Ammal Abbasi, Marcos Díaz‐Gay, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 30, pp. 3550-3560
Open Access | Times Cited: 9
Poly (adenosine diphosphate‐ribose) polymerase inhibitors in the treatment of triple‐negative breast cancer with homologous repair deficiency
Peng Yuan, Nan Ma, Binghe Xu
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2774-2792
Open Access | Times Cited: 6
New Achievements for the Treatment of Triple-Negative Breast Cancer
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Applied Sciences (2022) Vol. 12, Iss. 11, pp. 5554-5554
Open Access | Times Cited: 24
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer
Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1299-1299
Open Access | Times Cited: 14
Genomic Features of Homologous Recombination Deficiency in Breast Cancer: Impact on Testing and Immunotherapy
Umer Ali, Sunitha Vungarala, Venkataswarup Tiriveedhi
Genes (2024) Vol. 15, Iss. 2, pp. 162-162
Open Access | Times Cited: 5
The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair
Vilma Pacheco-Barcía, Andrés J. Muñoz Martín, Elena Castro, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2950-2950
Open Access | Times Cited: 19
Potential candidates for adjuvant olaparib treatment in operable breast cancer patients with germline BRCA1/2 pathogenic variants after neoadjuvant chemotherapy
Huimin Liu, Furong Kou, Li Hu, et al.
Breast Cancer Research and Treatment (2025)
Closed Access
Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer
Yimeng Chen, Xue Wang, Feng Du, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 2, pp. 155-168
Open Access | Times Cited: 7
Clinical Utility of Whole-Genome Analysis as One-for-All Test for Breast Cancer: A Case Series
Kabsoo Shin, Ryul Kim, Hansol Park, et al.
Case Reports in Oncology (2024) Vol. 17, Iss. 1, pp. 317-328
Open Access | Times Cited: 2
Identification of CXCL13 as a Promising Biomarker for Immune Checkpoint Blockade Therapy and PARP Inhibitor Therapy in Ovarian Cancer
Yue Ding, Ye Zheng, Bo Ding, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 2
Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study
Yongsheng Huang, Yuntan Qiu, Linxiaoxiao Ding, et al.
The Journal of Pathology Clinical Research (2024) Vol. 10, Iss. 2
Open Access | Times Cited: 1
Whole Genome Landscape Analysis of Homologous Recombination Deficiency in a Pan-Cancer Cohort
Majd Al Assaad, Kevin Hadi, Max F. Levine, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer
Jingyu Chen, Jian‐Di Li, Rong‐Quan He, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 7, pp. 867-894
Closed Access | Times Cited: 1
Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort
Orsolya Pipek, Donát Alpár, Orsolya Rusz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8553-8553
Open Access | Times Cited: 2
Naphthoquinone Derivative ZSW-4B Induces Apoptosis in Triple-negative Breast Cancer via AMPK signal Activation
Xiyuan Hu, Hongdou Liu, Tiao Luo, et al.
Research Square (Research Square) (2024)
Open Access
Poly(ADP-ribose) polymerase (PARP) inhibitors for BRCA-associated early triple-negative breast cancer: progress and future hopes
Sh. R. Abdullaeva, T. Yu. Semiglazova, A. S. Artemyeva, et al.
Medical Technologies Assessment and Choice (2024), Iss. 1, pp. 91-91
Open Access
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation
Xiyuan Hu, Hongdou Liu, Tiao Luo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Whole Genome Analysis Identifies Homologous Recombination Deficiency in Cancers with BRCA1/2 Wild-Type and BRCA1/2 Structural Variants
Juan Miguel Mosquera, Majd Al Assaad, Kevin Hadi, et al.
Research Square (Research Square) (2024)
Open Access
Electroporation enhances cell death in 3D scaffold-based MDA-MB-231 cells treated with metformin
Praveen Sahu, Ignacio G. Camarillo, Monica Dettin, et al.
Bioelectrochemistry (2024) Vol. 159, pp. 108734-108734
Open Access
Deciphering BRCAness Phenotype in Cancer: A Graph Convolutional Neural Network Approach with Layer-wise Relevance Propagation Analysis
Jingyu Yang, Hryhorii Chereda, Jürgen Dönitz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: the NOBROLA phase 2 study
Alfonso Cortés, Elena López-Miranda, Adela Fernández-Ortega, et al.
The Breast (2024) Vol. 78, pp. 103834-103834
Open Access
Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
Luo LiZhi, Sheng Li, Wei Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Real-world data in patients with BRCA mutated breast cancer treated with poly (ADP-ribose) polymerase inhibitors
Evelyn Lilian Beas-Lozano, Haydeé Cristina Verduzco-Aguirre, Roberto Gonzalez-Salazar, et al.
ecancermedicalscience (2023) Vol. 17
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top